| Name | Title | Contact Details |
|---|
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Little Spurs Pediatric Urgent Care is a medical group with 11 locations throughout the San Antonio area and three locations in Dallas. They provide urgent care for infants, kids, and teens up to age 21, with extended evening and weekend hours. Little S...
The Sequoia Project is a non-profit 501c3 chartered to advance implementation of secure, interoperable nationwide health information exchange. The Sequoia Project supports health IT interoperability initiatives, most notably: the eHealth Exchange, a rapidly growing community of exchange partners who share information under a common trust framework and a common set of rules; and Carequality, a public-private collaborative effort to build consensus among existing data sharing networks regarding technical specifications and best practices, much like the telecommunications industry did for linking cell phone networks. The Sequoia Project leads in cross-industry collaboration to develop implementation strategies that enable secure, interoperable nationwide exchange of health information.
Bostwick Laboratories, Inc. a specialized anatomic pathology laboratory focused on the diagnosis of cancer. The Company delivers diagnostic reports providing physicians with the ability to make treatment decisions with their patients.